Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • ADVERTISEMENT FEATURE Advertiser retains sole responsibility for the content of this article

Collaborative Research and Licensing Opportunity: Polyvalent Influenza Virus-Like Particles (VLPs) and Their Use as Vaccines

This virus-like particle (VLP) vaccine technology for influenza viruses may be utilized for the development of an universal influenza virus vaccine.

Produced by

Nature Research Custom Media
NIAID Technology Transfer and Intellectual Property Office

This virus-like particle (VLP) vaccine technology for influenza viruses, based on a mixture of VLPs expressing the hemagglutinin protein or the neuraminidase protein from influenza virus strains belonging to different virus subtypes, has demonstrated broad protection against lethal challenge in mice with various influenza virus strains and virus subtypes. Results from ferret and mouse studies demonstrate broad heterosubtypic protection against various influenza virus subtypes further supporting and strengthening the proposed application of this technology as a universal influenza virus vaccine.

Potential Commercial Applications:

• Universal Flu Vaccine

Competitive Advantages:

• broad/universal protection against influenza viruses

• does not require reformulating vaccine each year as is currently necessary with vaccines available on the market

• can potentially provide protection against novel influenza viruses that may arise in the future, including potentially pandemic influenza viruses

Publications:

Schwartzman, et al. An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus. 2015. MBio. 6(4): e01044-15.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC45130...

Intellectual Property: U.S. Provisional Application No. 62/014,814; PCT/US2015/029843

Search

Advanced search

Quick links